MicroRNA reprogramming by oncogenes and tumor suppressors
Wednesday, February 22, 2012
12:00 pm - 1:00 pm
Joshua Mendell, MD, PhD, UT Southwestern Medical Center
Structures and mechanism of Lin28, a multifunctional microRNA regulator
Sponsor(s):
Pharmacology and Cancer Biology
Tuesday, February 28, 2012
11:30 am - 12:30 pm
Yunsun Nam, PhD, Harvard Medical School
DNA damage responses: Bedside to bench to bedside
Wednesday, February 29, 2012
12:00 pm - 1:00 pm
Michael Kastan, MD, PhD, Duke Cancer Institute
Control of organ size and tumorigenesis by the Hippo signaling pathway
Wednesday, March 07, 2012
12:00 pm - 1:00 pm
Duojia Pan, PhD, Johns Hopkins University School of Medicine
Once in a lifetime: Control of cell fate and architecture by an Mst/hippo signaling system
Wednesday, March 14, 2012
12:00 pm - 1:00 pm
Eric Weiss, PhD, Northwestern University
Modulation of cell signaling and oncogenesis by a human tumor virus
Wednesday, March 21, 2012
12:00 pm - 1:00 pm
Blossom Damania, PhD, UNC-Chapel Hill
Harnessing cancer genome diversity for intervention target identification and development
Wednesday, March 28, 2012
12:00 pm - 1:00 pm
Michael White, PhD, UT Southwestern Medical Center
BCR-ABL-independent factors which prevent the control of chronic myelogenous leukemia
Wednesday, April 04, 2012
12:00 pm - 1:00 pm
S. Tiong Ong, MD, Duke-NUS
Role of PtdIns(3,5)P2 and Ptdlns5P, lipids with unexpected links to neurodegenerative disease
Wednesday, April 11, 2012
12:00 pm - 1:00 pm
Lois Weisman, PhD, University of Michigan
Subnanometer Cryo-EM structures of complex eukaryotic assemblies: kinetochore and proteosome
Wednesday, April 18, 2012
12:00 pm - 1:00 pm
Eva Nogales, PhD, University of California, Berkeley (Fitzgerald Distinguished Lecturer)
"Enabling Structure-based design: the crystal structure of NF-kappaB inducing kinase"
Friday, July 06, 2012
11:00 am - 12:00 pm
Sarah G. Hymowitz, PhD
Altering the tau homeostasis through the heat shock protein 70 (Hsp70) chaperone system
Wednesday, September 12, 2012
12:00 pm - 1:00 pm
Jason Gestwicki, PhD, University of Michigan
Duke Fly Club- September
Tuesday, September 18, 2012
4:15 pm - 5:15 pm
Leyna Denapoli and Ginger Hunter, PhD
ABL family kinase signaling networks in cancer and immunity
Wednesday, September 19, 2012
12:00 pm - 1:00 pm
Ann Marie Pendergast, PhD, Duke University School of Medicine
Chromatin determinants of the eukaryotic DNA replication program
Wednesday, September 26, 2012
12:00 pm - 1:00 pm
David MacAlpine, PhD, Duke University School of Medicine
New functional genomics tools to study and manipulate oncogenic signaling networks
Wednesday, October 03, 2012
12:00 pm - 1:00 pm
Kris Wood, PhD, Duke University School of Medicine
A closer look at signaling by tyrosine kinases
Wednesday, October 10, 2012
12:00 pm - 1:00 pm
Bruce Mayer, PhD, University of Connecticul Health Center
Regulation of the proteasome by ubiquitin chain editing
Wednesday, October 17, 2012
12:00 pm - 1:00 pm
Daniel Finley, PhD, Harvard Medical School
Mouse models of lung cancer
Wednesday, October 24, 2012
12:00 pm - 1:00 pm
Kwok-Kin Wong, MD, PhD, Dana-Farber Cancer Institute
Clear cell renal cell carcinoma genomics
Wednesday, October 31, 2012
12:00 pm - 1:00 pm
W. Kimryn Rathmell, MD, PhD, UNC-Chapel Hill
Metabolism and cancer: Why should we care?
Sponsor(s):
Pharmacology and Cancer Biology, Duke Cancer Institute, Sarah Stedman Center for Nutrition, and Department of Medicine
Monday, November 05, 2012
12:00 pm - 1:00 pm
Eyal Gottlieb, MD, PhD, The Beatson Institute for Cancer Research
Identifying new genes and therapies in Ras driven cancers
Wednesday, November 07, 2012
12:00 pm - 1:00 pm
Karen Cichowski, PhD, Harvard Medical School
Metabolomic analysis of human pancreatic tumors reveals scavenging of albumin and lysolipids: Opportunities for novel therapeutic strategies?
Sponsor(s):
Pharmacology and Cancer Biology, Duke Cancer Institute, Department of Medicine, and Sarah Stedman Center for Nutrition
Monday, November 12, 2012
4:30 pm - 5:30 pm
Jurre Kamphorst, PhD, Princeton University
Regulation of metabolism to support cell proliferation
Wednesday, November 14, 2012
12:00 pm - 1:00 pm
Matthew Vander Heiden, MD, PhD, MIT
Molecular sex and the mitochondrial genome
Wednesday, November 28, 2012
12:00 pm - 1:00 pm
Patrick O'Farrell, PhD, UCSF
Sirt3 is a mammary tumor suppressor SIRTainty
Wednesday, December 05, 2012
12:00 pm - 1:00 pm
David Gius, MD, PhD, Northwestern University
Cancer metabolism: Approaches, Insights, and Opportunities
Sponsor(s):
Pharmacology and Cancer Biology, Duke Cancer Institute, Department of Medicine, and Sarah Stedman Center for Nutrition
Monday, December 17, 2012
10:00 am - 11:00 am
Ralph DeBerardinis, MD, PhD, UT Southwestern Medical Center
Visualizing Cancer Metabolism as it happens with Hyperpolarized Magnetic Resonance
Sponsor(s):
Pharmacology and Cancer Biology, Duke Cancer Institute, Sarah W. Stedman Nutrition and Metabolism Center, and School of Medicine (SOM)
Wednesday, January 09, 2013
12:00 pm - 1:00 pm
Kayvan Keshari, PhD, UCSF
Targeting the heterogeneous Ras signaling network in T cell Leukemia
Wednesday, January 16, 2013
12:00 pm - 1:00 pm
Jeroen Roose, PhD, UCSF
Regulation of cell survival during morphogenesis and oncogenesis
Wednesday, January 23, 2013
2:00 pm - 3:00 pm
Joan Brugge, PhD, Harvard Medical School
Membrane Trafficking of Ras
Wednesday, January 30, 2013
12:00 pm - 1:00 pm
Mark Philips, MD, New York University School of Medicine
Cancer Genomics: What's next?
Wednesday, February 06, 2013
12:00 pm - 1:00 pm
John Maris, MD, The Children's Hospital of Philadelphia
miRNAs at the crossroads between cancer and induced pluripotency
Wednesday, February 13, 2013
12:00 pm - 1:00 pm
Lin He, PhD, UC, Berkeley
Histone modifications regulate DNA replication coupled nucleosome assembly
Wednesday, February 20, 2013
12:00 pm - 1:00 pm
Zhiguo Zhang, PhD, Mayo Clinic
Regulating Wnts at the source: Inhibition of Wnt secretion for science and profit
Wednesday, February 27, 2013
12:00 pm - 1:00 pm
David Virshup, MD, Duke-NUS
More Events
(40 of 357)
